U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer
Approval is based on CROWN trial, which showed a 72% reduction in risk of progression or death for treatment with
Read morePharmaceutical Company News
The latest news from the pharmaceutical sector. Covering the latest breaking news, encompassing company news from leading pharmaceutical companies and related companies.
EISAI TO SUPPORT CONSTRUCTION OF SCREENING FRAMEWORK FOR THE NOVEL CORONAVIRUS INFECTION IN KENYA | News Release：2021
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has decided to assent to and support
Read moreSanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members
Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members Paris, France – March
Read moreAmgen Announces 2021 Second Quarter Dividend
THOUSAND OAKS, Calif., March 3, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76
Read moreTakeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
Osaka, Japan, and New York, March 3, 2021 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and Ovid Therapeutics Inc. (NASDAQ:
Read moreVir Biotechnology and GSK provide update on NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19 | GSK
For media and investors only Issued: London UK Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today provided
Read moreUS court decision favours Symbicort in patent litigation
3 March 2021 07:00 GMT The US District Court for the Northern District of West Virginia has decided in favour
Read moreJohnson & Johnson Statement on Collaboration with Merck
Johnson & Johnson Statement on Collaboration with Merck | Johnson & Johnson Skip to content Our Company Johnson & Johnson
Read moreBLINCYTO® (Blinatumomab) Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
THOUSAND OAKS, Calif., March 2, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that data from a multicenter, randomized Phase 3
Read moreNovartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting | Novartis
Shareholders approve 24th consecutive dividend increase to CHF 3.00 (+1.7%) per share for 2020; representing a 3.8% yield1 and approximately
Read moreAstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX
2 March 2021 12:15 GMT Supply to 142 countries underway as part of the unprecedented effort to bring broad and
Read moreViiV Healthcare to present new data on long-acting regimens for HIV prevention and treatment, alongside pipeline advances at CROI 2021 | GSK
For media and investors only Issued: London, UK Data presented will demonstrate the potential of new antiretroviral mechanisms of action
Read moreTake a visual tour of medicines that target RNA | Novartis
Cells have a built-in search and delete function. The existence of such a system came as a surprise 30 years
Read moreA Delicious Snack That’s Good for You Announcing SOYJOY Coffee & Nuts Soy protein from low-GI whole soy｜News Releases | Otsuka Pharmaceutical Co., Ltd.
March 2, 2021 Otsuka Pharmaceutical Co., Ltd. Nutraceuticals Otsuka Pharmaceutical Co., Ltd. (Otsuka) has announced the launch of SOYJOY Coffee
Read moreNEW DRUG APPROVAL FOR IN-HOUSE DEVELOPED ANTI-INSOMNIA DRUG DAYVIGO® (LEMBOREXANT) IN HONG KONG | News Release：2021
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co.,
Read moreFurther update on US regulatory review of roxadustat in anaemia of chronic kidney disease
This announcement contains inside information 1 March 2021 21:01 GMT AstraZeneca and FibroGen, Inc. (FibroGen) today announced that the US
Read moreOn a mission to transform planetary health
“Planetary health is directly related to human health and if we don’t change, the human species will disappear.” This was
Read moreJohnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.
NEW BRUNSWICK, N.J., February 28, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Centers
Read moreXevinapant – News | Merck global
01 Mar 2021 | Darmstadt, Germany Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation
Read moreJohnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food
Read moreRegeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma | Regeneron Pharmaceuticals Inc.
TARRYTOWN, N.Y., Feb. 27, 2021 /PRNewswire/ — Single administration of novel antibody cocktail controlled patients’ allergic response to cat allergen,
Read moreJohnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
Vote based on totality of scientific evidence provided by the Company including safety and efficacy data NEW BRUNSWICK, N.J., February
Read moreRoche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany
Special approval from German Federal Institute for Drugs and Medical Devices (BfArM) enables home use of a SARS-CoV-2 Rapid Antigen
Read moreTezepelumab is the first biologic to consistently and significantly reduce exacerbations in broad population of severe asthma patients
26 February 2021 14:00 GMT Tezepelumab demonstrated superiority versus placebo across every primary and key secondary endpoint in NAVIGATOR Phase
Read more